Digest Network Come funziona
Network
/
Società
Ha
Non verificato

Harmony Biosciences Holdings, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieSaluteWeb e Social Network

35 comunicati stampa

Guarda tutti i comunicati
23/04/2026
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Harmony Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026
Fonte
Harmony Biosciences Holdings, Inc.
Emittente
Business Wire
1.00
0
16/04/2026
Eventi
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Harmony Biosciences to Present Open-Label Extension Data From Phase 3 ARGUS Trial at the 2026 American Academy of Neurology Annual Meeting
Fonte
Harmony Biosciences Holdings, Inc.
Emittente
Business Wire
1.00
0
14/04/2026
Mercato del lavoro
Biotecnologia
Sanità
Salute
Farmaceutica
Harmony Biosciences Appoints Glenn Reicin as Chief Financial Officer
Fonte
Harmony Biosciences Holdings, Inc.
Emittente
Business Wire
1.00
0
02/04/2026
Mercato del lavoro
Salute
Scienza
Farmaceutica
Harmony Biosciences Strengthens Executive Team With New Appointment and Announces Additions to Its Board
Fonte
Harmony Biosciences Holdings, Inc.
Emittente
Business Wire
1.00
0
31/03/2026
Eventi
Web e Social Network
Biotecnologia
Sanità
Salute
Farmaceutica
Harmony Biosciences to Participate in 25th Annual Needham Virtual Healthcare Conference
Fonte
Harmony Biosciences Holdings, Inc.
Emittente
Business Wire
1.00
0
04/03/2026
Eventi
Salute
Medicina - Varie
Sanità
Farmaceutica
Biotecnologia
Harmony Biosciences to Participate in Upcoming Investor Conferences
Fonte
Harmony Biosciences Holdings, Inc.
Emittente
Business Wire
1.00
0
24/02/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Scienza
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Sanità
Harmony Biosciences Reports Strong 2025 Financial Results and Reiterates 2026 Net Revenue Guidance of Over $1 Billion
Fonte
Harmony Biosciences Holdings, Inc.
Emittente
Business Wire
1.00
0
17/02/2026
Industria
Biotecnologia
Farmaceutica
Salute
Igiene alimentare
Famiglia
Infanzia
Vetrine/Shopping
Medicina - Varie
Harmony Biosciences Receives U.S. Food and Drug Administration Approval for WAKIX® (pitolisant) for the Treatment of Cataplexy in Pediatric Narcolepsy
Fonte
Harmony Biosciences Holdings, Inc.
Emittente
Business Wire
1.00
0
10/02/2026
Biotecnologia
Farmaceutica
Salute
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Harmony Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
Fonte
Harmony Biosciences Holdings, Inc.
Emittente
Business Wire
1.00
0
12/01/2026
Salute
Medicina - Varie
Sanità
Farmaceutica
Biotecnologia
Industria
Harmony Biosciences Guides to Over $1 Billion in WAKIX® Revenue in 2026; Advancing Robust Late-Stage Pipeline With Potential for Long-term Value Creation
Fonte
Harmony Biosciences Holdings, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0